Immuno-augmentation therapy (IAT), also called immuno-augmentative or immuno-augmentive therapy, is a cancer treatment aimed at restoring the immune system with injections of a mixture of blood factors.

Anecdotal reports from patients indicate that the side effects of IAT are minor

In April 2003, the United States Agency for Healthcare Research and Quality (AHRQ) issued a report on IAT.

Replacement AAT (Prolastin), derived from human blood which has been screened for viruses, is injected weekly or bimonthly for life

Some experimental treastments are: Immuno-vaccines are still very new to the brain tumor arena, and Proton therapy (also called proton beam therapy).